Search
You have searched for "Pets"
Showing 21-30 of 66
Colgate 1Q net rises 61% but margins fall
NEW YORK: Consumer-goods giant Colgate-Palmolive Co.'s net income soared 61 percent in the first quarter, the company reported Thursday. But under that buoyant figure, Colgate is feeling the squeeze of higher costs for fuel and other raw materials.
Pfizer unit Zoetis IPO raises US$2.2bil
New York: Pfizer Inc’s animal health subsidiary Zoetis raised US$2.2bil in its public offering, becoming the largest IPO from a US company since Facebook.
InfoValley makes new foray
KUALA LUMPUR: iGene Sdn Bhd and InfoValley Life Sciences Sdn Bhd are bringing their digital imaging technology to the animal industry with an initial outlay of US$6mil (RM18mil).
Demand Media acquires e-commerce marketplace
NEW YORK: Demand Media, the owner of content websites eHow, Livestrong and Cracked, said on Monday it had acquired the e-commerce marketplace Society6 for US$94 million in cash and stock as the company diversifies its business model.
Boyhood love of snakes grows into a profession for pet shop owner
WATER Leong has been fascinated by snakes since he was a boy, so much so that he secretly kept one as a pet in his room.
2013 has been biggest for equity fundraising globally since 2010
LONDON/NEW YORK/HONG KONG: This year has been the biggest for equity fundraising globally since 2010, thanks to improving confidence among companies on the back of the strong investor demand for stocks, according to Thomson Reuters data published on Friday.
On investing: The patient and the brave
REUTERS: There are two main ways to get paid as a value investor: one is by avoiding the mistakes of your peers, the other is by making some mistakes of your own.
Gourmet meals for pets
IF YOU thought that “fine-dining” was a concept applicable only to people, think again.
Novartis and GSK trade assets as pharma industry reshapes
ZURICH/LONDON: Novartis and GlaxoSmithKline agreed to trade more than $20 billion worth of assets on Tuesday to bolster their best businesses and exit weaker ones as the drug industry contends with healthcare spending cuts and generic competition.
